Boone Capital Management’s RAPT Therapeutics RAPT Stock Holding History

Boone Capital Management’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-470,456	Closed	-$15.9M	–	17
2025 Q4	$15.9M	Sell	470,456 -312,005	-40%	-$9.69M	5%	11
2025 Q3	$20.2M	Buy	+782,461	New	+$10.2M	6.62%	7

Boone Capital Management's RAPT Position: Q1 2026 in Review

Boone Capital Management sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 470,456 shares — an estimated $15.9M sold.

Boone Capital Management first reported a position in RAPT in Q3 2025 and held it in 2 quarters. The position peaked at $20.2M in Q3 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Boone Capital Management reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Boone Capital Management sold 470,456 RAPT Therapeutics shares in Q1 2026, an estimated $15.9M.
Boone Capital Management first reported a position in RAPT Therapeutics in Q3 2025 and held it in 2 quarters.
Boone Capital Management's RAPT Therapeutics position peaked at $20.2M in Q3 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Boone Capital Management's 13F filing for Q1 2026, filed 15 May 2026.